Fedenia Advisers LLC Astrazeneca PLC Transaction History
Fedenia Advisers LLC
- $154 Billion
- Q1 2025
A detailed history of Fedenia Advisers LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fedenia Advisers LLC holds 4,820 shares of AZN stock, worth $356,583. This represents 0.23% of its overall portfolio holdings.
Number of Shares
4,820
Previous 6,746
28.55%
Holding current value
$356,583
Previous $442 Million
19.85%
% of portfolio
0.23%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.22 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.01 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...